Long-term treatment of Parkinson's disease with bromocriptine.
Authors:
- A RascolARA Rascol
- B GuiraudBGB Guiraud
- J L MontastrucJMJ L Montastruc
- J DavidJDJ David
- M ClanetMCM Clanet
Open Access
- 1 February 1979
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 42 (2) , 143-150
Abstract
BRomocriptine (15-75 mg per day) alone or with L-dopa was studied during five to 29 months on 44 patients with Parkinson's disease. Used as sole therapeutic agent, it was found excellent in 12 patients who had never received regular L-dopa treatment either because it was never attempted or because of intolerance from the outset. Its anti-Parkinsonism activity was comparable with L-dopa. The gain was stable in the long term until this report. The side effects of L-dopa were not seen after bromocriptine. In cases where L-dopa had ceased to be active, bromocriptine produced a further improvement if mental deterioration was not associated. In very advanced forms of Parkinson's disease with associated dementia, bromocriptine did not produce durable results. Bromocriptine did not improve the "on-off" effects but reduced a number of the side effects of L-dopa, in particular cardiac, painful contractions, and dyskinesia without "on-off" effects.Keywords
This publication has 20 references indexed in Scilit:
- SUCCESS AND PROBLEMS OF LONG-TERM LEVODOPA THERAPY IN PARKINSON'S DISEASEThe Lancet, 1977
- Central dopaminergic receptor supersensitivity and its relevance to Parkinson's diseaseJournal of the Neurological Sciences, 1977
- BROMOCRIPTINE AND LEVODOPA (WITH OR WITHOUT CARBIDOPA) IN PARKINSONISMThe Lancet, 1976
- Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnoverJournal of Pharmacy and Pharmacology, 1976
- Bromocriptine treatment in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1976
- BROMOCRIPTINE IN PARKINSONISMThe Lancet, 1975
- Effect of ergot drugs on central 5-hydroxytryptamine neurons: Evidence for 5-hydroxytryptamine release or 5-hydroxytryptamine receptor stimulationEuropean Journal of Pharmacology, 1975
- TREATMENT OF PARKINSONISM WITH BROMOCRIPTINEThe Lancet, 1974
- Bromocriptine in ParkinsonismBMJ, 1974
- Effect of ergot drugs on central catecholamine neurons: Evidence for a stimulation of central dopamine neuronsJournal of Pharmacy and Pharmacology, 1973